ATE59144T1 - Verfahren zur herstellung von gamma-globulin zur intravenoesen anwendung. - Google Patents

Verfahren zur herstellung von gamma-globulin zur intravenoesen anwendung.

Info

Publication number
ATE59144T1
ATE59144T1 AT84107985T AT84107985T ATE59144T1 AT E59144 T1 ATE59144 T1 AT E59144T1 AT 84107985 T AT84107985 T AT 84107985T AT 84107985 T AT84107985 T AT 84107985T AT E59144 T1 ATE59144 T1 AT E59144T1
Authority
AT
Austria
Prior art keywords
concn
preparation
ppte
sepd
impure
Prior art date
Application number
AT84107985T
Other languages
English (en)
Inventor
Juergen-Dietrich Fried Fiechtl
Bernhard Dr Kerner
Juergen Holzapfel
Martin Dr Puschmann
Tokusuke Kimura
Fumio Kurosu
Original Assignee
Armour Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma Gmbh filed Critical Armour Pharma Gmbh
Application granted granted Critical
Publication of ATE59144T1 publication Critical patent/ATE59144T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT84107985T 1984-07-07 1984-07-07 Verfahren zur herstellung von gamma-globulin zur intravenoesen anwendung. ATE59144T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP84107985A EP0168506B2 (de) 1984-07-07 1984-07-07 Verfahren zur Herstellung von gamma-Globulin zur intravenösen Anwendung
JP7263622A JPH08319241A (ja) 1984-07-07 1995-09-19 静脈注射用ガンマグロブリン組成物

Publications (1)

Publication Number Publication Date
ATE59144T1 true ATE59144T1 (de) 1991-01-15

Family

ID=26091956

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84107985T ATE59144T1 (de) 1984-07-07 1984-07-07 Verfahren zur herstellung von gamma-globulin zur intravenoesen anwendung.

Country Status (8)

Country Link
EP (1) EP0168506B2 (de)
JP (2) JPH0816065B2 (de)
AT (1) ATE59144T1 (de)
DE (1) DE3483784D1 (de)
DK (1) DK164023C (de)
FI (1) FI84136C (de)
NO (1) NO168943C (de)
WO (1) WO1986000530A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
EP3088412B1 (de) 2001-03-09 2021-05-05 Chugai Seiyaku Kabushiki Kaisha Proteinaufreinigungsverfahren
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
BR112014004445B1 (pt) 2011-08-26 2022-11-22 Takeda Pharmaceutical Company Limited Método para reduzir conteúdo de fator xi e/ou fator xia em uma composição de imunoglobulina

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126605A (en) * 1975-12-29 1978-11-21 Plasmesco Ag Process of improving the compatibility of gamma globulins
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
JPS5732228A (en) * 1980-08-05 1982-02-20 Green Cross Corp:The Preparation of immunoglobulin usable for intravenous injection
JPS57203017A (en) * 1981-06-09 1982-12-13 Fujirebio Inc Purifying method of immunoglobulin
EP0078331B1 (de) * 1981-10-29 1986-01-29 Green Cross Corporation Verfahren zur Herstellung von intravenösem injizierbarem Immunoglobulin

Also Published As

Publication number Publication date
JPS61500972A (ja) 1986-05-15
NO860848L (no) 1986-03-06
DE3483784D1 (de) 1991-01-31
DK164023B (da) 1992-05-04
EP0168506A1 (de) 1986-01-22
DK97286A (da) 1986-03-04
DK164023C (da) 1992-09-28
EP0168506B1 (de) 1990-12-19
FI84136C (fi) 1991-10-25
EP0168506B2 (de) 1998-01-07
NO168943C (no) 1992-04-22
WO1986000530A1 (en) 1986-01-30
NO168943B (no) 1992-01-13
FI860350A (fi) 1986-01-24
JPH0816065B2 (ja) 1996-02-21
JPH08319241A (ja) 1996-12-03
DK97286D0 (da) 1986-03-04
FI860350A0 (fi) 1986-01-24
FI84136B (fi) 1991-07-15

Similar Documents

Publication Publication Date Title
Miller et al. Liver injury, liver protection, and sulfur metabolism: methionine protects against chloroform liver injury even when given after anesthesia
SE7903817L (sv) Moranolinderivat
ATE84967T1 (de) Verwendung von pentoxifyllin zur behandlung entzuendlicher erkrankungen.
DK0454898T3 (da) Glycosaminoglycan-modificeret protein, fremgangsmåde til fremstilling af proteinet, farmaceutiske præparater indeholdende proteinet samt anvendelse af proteinet
DE69630918D1 (de) Matrix für Iontophorese
GB1495159A (en) Process reducing the anticomplementary activity of gamma globulins
FI102293B1 (fi) Ihmisen interleukiini-3:n molekulaarinen kloonaus ja ilmentäminen
FI844557L (fi) Koncentrat av antihemofilfaktorn viii och foerfarande foer framstaellning av detsamma.
ATE59144T1 (de) Verfahren zur herstellung von gamma-globulin zur intravenoesen anwendung.
ATE200518T1 (de) Hydroxyprolin reiche proteine und sie enthaltende pharmazeutische und kosmetische zubereitungen
GB779493A (en) Process for the isolation of stable, highly purified gamma globulin preparations
ATE59554T1 (de) Auf mercaptoethansulfonsaeuren basierende pharmazeutische zusammensetzungen, organische abkoemmlinge von mercaptoethansulfonsaeuren sowie verfahren zu deren herstellung.
GB1526617A (en) 2 and 3-substituted enkephalins
Golub et al. The inhibition of the maturation of newly synthesized bone collagen by β-aminopropionitrile in tissue culture
ATE44750T1 (de) Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats.
GB1526205A (en) Treatment of interferon-like material
NL7017514A (en) Purification of proteins
Kishi et al. Young age-related glycoproteins revealed in normal human urine by isoelectric focusing
Chiang et al. Collagen-platelet interaction: Type XI collagen-induced platelet aggregation
GB1229988A (de)
Foá-Tomasi et al. Enhanced inhibition of RNA synthesis by amanitins in in vitro cultured cells
SU1676628A1 (ru) Противоалкогольное средство "Гликал
GB1204534A (en) Process for the purification of sewage
Nellas et al. Pancreatic collagenase therapy for severe, progressive systemic sclerosis: Effect on skin and on hydroxyproline content in urine
GB1159548A (en) Surgical Adhesives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee